Mode
Text Size
Log in / Sign up

Mechanical thrombectomy shows potential for favorable outcomes in pediatric large-vessel occlusion strokeMechanical Thrombectomy May Help Children After Stroke

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that while some comparisons favor mechanical thrombectomy, evidence is currently insufficient to confirm its superiority.

This meta-analysis synthesizes data from observational studies to evaluate the efficacy of mechanical thrombectomy (MT) in pediatric patients with large-vessel occlusion (LVO). The analysis compared MT against medical management, intravenous thrombolysis (IVT), and conservative treatment.

Key findings include a non-significant difference in favorable outcomes when comparing MT to general medical management (OR 1.83; 95% CI 0.97-3.43). However, exploratory Bayesian inference supported the finding of favorable outcomes for MT over medical management (OR 1.75; 95% CrI 1.05-2.67; BF10 5.05). Specific comparisons showed statistically significant benefits for MT over IVT (OR 2.39; 95% CI 1.19-4.79) and over conservative treatment (OR 2.22; 95% CI 1.41-3.51). Regarding mortality rates, the evidence was insufficient to detect or exclude a difference between MT and medical management (OR 1.32; 95% CI 0.45-3.89).

The authors note several limitations, including low certainty due to small sample sizes and the fact that trial sequential analysis indicated the required information size was not reached. The findings are currently considered hypothesis-generating only. Consequently, adequately powered prospective studies are necessary before MT can be formally recommended for pediatric LVO.

How this fits prior evidence

This meta-analysis addresses a gap in evidence regarding mechanical thrombectomy specifically for pediatric patients with large-vessel occlusion. While prior coverage noted that intravenous thrombolysis combined with endovascular treatment improves 90-day functional independence in tandem lesion stroke, this study focuses on the specific comparison of MT against IVT and conservative management in the pediatric population. The results provide a basis for further investigation into MT's role in pediatric stroke care.

A new analysis of observational studies suggests that mechanical thrombectomy, a procedure to remove blood clots, may help children who have had a severe type of stroke called large-vessel occlusion. However, the findings are not definitive, and more research is needed before this treatment can be widely recommended for children.

The analysis combined data from 436 children, 230 of whom received mechanical thrombectomy, while 206 received medical management, which could include intravenous thrombolysis (clot-busting drugs) or conservative care. The main goal was to see if mechanical thrombectomy led to better outcomes, such as improved recovery and function.

When comparing mechanical thrombectomy to medical management as a whole, the analysis found no statistically significant difference in favorable outcomes. However, when the researchers used a different statistical method (Bayesian inference), they found a positive effect, and when they compared mechanical thrombectomy directly to intravenous thrombolysis or conservative treatment, they found that mechanical thrombectomy was associated with better outcomes. For example, the odds of a favorable outcome were about 2.4 times higher with mechanical thrombectomy than with intravenous thrombolysis, and about 2.2 times higher than with conservative treatment.

The analysis did not find enough evidence to determine whether mechanical thrombectomy affects the risk of death, and the authors caution that the findings are hypothesis-generating, not proof. The study was limited by its small sample size and the fact that it was based on observational data, which cannot prove cause and effect.

For now, this analysis suggests that mechanical thrombectomy might be a promising option for children with large-vessel occlusion stroke, but larger, more rigorous studies are needed to confirm these findings and to guide treatment decisions. If your child has had a stroke, talk to their doctor about the best treatment options.

What this means for you:
Mechanical thrombectomy may improve outcomes in children with large-vessel occlusion stroke, but more research is needed before it can be routinely recommended.

Common questions

What is mechanical thrombectomy?

Mechanical thrombectomy is a procedure to remove a blood clot from a blood vessel. In this analysis, it was used in children with large-vessel occlusion stroke, a severe type of stroke. The procedure aims to restore blood flow to the brain and improve outcomes.

Who might benefit from mechanical thrombectomy for stroke?

This analysis focused on children with large-vessel occlusion stroke. It found that mechanical thrombectomy was associated with better outcomes compared to intravenous thrombolysis or conservative treatment. However, the findings are not definitive, and more research is needed to determine which children might benefit most.

Is mechanical thrombectomy safe for children?

The analysis did not report on safety concerns, such as adverse events or side effects. The authors noted that the evidence is insufficient to detect or exclude a difference in mortality rates. Therefore, the safety of mechanical thrombectomy in children is not fully established, and more research is needed.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
OBJECTIVE: To investigate the outcome of pediatric large vessel occlusion (LVO) treated with mechanical thrombectomy (MT). INTRODUCTION: Pediatric LVO is a rare subtype of ischemic stroke. In adults, MT is recommended; however, the efficacy and safety of MT in pediatric LVO are less explored. The available studies are mostly observational studies; yet, these studies show inconsistent findings. METHOD: This review adhered to the PRISMA 2020 guideline. Studies comparing MT with medical management in pediatric with LVO were included. The primary endpoint was the favourable outcome. The mortality rate was sought as well. Subgroup analysis compared MT with intravenous thrombolysis (IVT) and conservative management. Post hoc exploratory analyses comprised Bayesian inference and trial sequential analysis (TSA). RESULT: Six studies comprising a total of 230 MT-treated and 206 non-MT patients were included. In the primary analysis, favourable outcome did not differ significantly between the MT and medical management groups (OR 1.83; 95% CI 0.97-3.43), while supported by exploratory Bayesian inference (OR 1.75; 95% CrI 1.05-2.67; BF10 5.05). Subgroup analysis showed favourable outcomes of MT over IVT (OR 2.39; 95% CI 1.19-4.79) and conservative treatment (OR 2.22; 95% CI 1.41-3.51), although the Bayesian model did not support these findings. The available evidence was insufficient to detect or exclude a difference in mortality between MT and medical management (OR 1.32; 95% CI 0.45-3.89). TSA indicated that the required information size was not reached and that additional trials are needed to reach the minimum sample requirements. CONCLUSION: In this synthesis of observational data, the MT may be associated with favourable outcome in pediatric LVO, however, these findings are hypothesis-generating only. Adequately powered prospective studies are needed before MT can be recommended for pediatric LVO. CLINICAL TRIAL NUMBER: not applicable.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.